摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

9(E)-phenanthrene-9,10-dione[(1Z)-3,3-dimethyl-3,4-dihydroisoquinolin-1(2H)-ylidene]-hydrazone | 1218901-69-9

分子结构分类

中文名称
——
中文别名
——
英文名称
9(E)-phenanthrene-9,10-dione[(1Z)-3,3-dimethyl-3,4-dihydroisoquinolin-1(2H)-ylidene]-hydrazone
英文别名
(9E)-phenanthrene-9,10-dione[(1Z)-3,3-dimethyl-3,4-dihydroisoquinolin-1(2H)-ylidene]hydrazone;9(E)-phenanthrene-9,10-dione[(1Z)-3,3-dimethyl-3,4-dihydroisoquinolin-1(2H)-ylidene]hydrazone
9(E)-phenanthrene-9,10-dione[(1Z)-3,3-dimethyl-3,4-dihydroisoquinolin-1(2H)-ylidene]-hydrazone化学式
CAS
1218901-69-9
化学式
C25H21N3O
mdl
——
分子量
379.461
InChiKey
BVMXEAMBDVEHSI-HPNDGRJYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.63
  • 重原子数:
    29.0
  • 可旋转键数:
    1.0
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.16
  • 拓扑面积:
    53.82
  • 氢给体数:
    1.0
  • 氢受体数:
    3.0

反应信息

  • 作为反应物:
    描述:
    9(E)-phenanthrene-9,10-dione[(1Z)-3,3-dimethyl-3,4-dihydroisoquinolin-1(2H)-ylidene]-hydrazone 在 cobalt(II) bromide hexahydrate 作用下, 以 乙醇异丙醇乙腈 为溶剂, 生成 (9E)-phenanthrene-9,10-dione[(1Z)-3,3-dimethyl-3,4-dihydroisoquinolin-1(2H)-ylidene]hydrazonium bromide
    参考文献:
    名称:
    Isomeric form and proton localization in (9E)-phenanthrene-9,10-dione[(1Z)-3,3-dimethyl-3,4-dihydroisoquinolin-1(2H)-ylidene]hydrazonium bromide
    摘要:
    (9E)-Phenanthrene-9,10-dione[(1Z)-3,3-dimethyl-3,4-dihydroisoquinolin-1(2H)-ylidene]hydrazonium bromide (LH)Br (I) 被合成。通过量子化学方法计算了 LH(+) 离子的质子化形式的模型,并对其相对稳定性进行了估计。化合物 I 的晶体结构通过 X 射线衍射分析确定。化合物 I 是以阳离子-阴离子型构建的(移动的质子位于氮原子上)。阳离子以 s-cis,cis-异构形式存在,并由两个环状氢键稳定。π 电子密度分布在多重键 N(1)-C(1)(1.292(4)) 和 N(3)-C(12)(1.294(4)) 上。获得了化合物 I 的光谱特性(红外光谱和电子吸收光谱)。
    DOI:
    10.1134/s0036023610050086
点击查看最新优质反应信息

文献信息

  • Synthesis, crystal structure, and electronic structure of a copper(II) chloride complex with 9(E)-phenanthrene-9,10-dione[(1Z)-3,3-dimethyl-3,4-dihydroisoquinolin-1(2H)-ylidene]hydrazone [Cu2(L-H)2Cl2]
    作者:V. V. Davydov、V. I. Sokol、N. V. Rychagina、R. V. Linko、M. A. Ryabov、P. V. Strashnov、V. S. Sergienko
    DOI:10.1134/s0036023614090046
    日期:2014.9
  • Synthesis, crystal structure, and spectra of the trichloromethane solvate of nickel(II) 9(E)-phenanthrene-9,10-dione[(1Z)-3,3-dimethyl-3,4-dihydroisoquinolin-1(2H)-ylidene]hydrazonate
    作者:V. V. Davydov、V. I. Sokol、N. V. Rychagina、R. V. Linko、Yu. V. Shklyaev、V. S. Sergienko
    DOI:10.1134/s003602361105007x
    日期:2011.5
    The complex [Ni(L-H)(2)] center dot CHCl3 (I), where L-H is the (9E)-phenanthrene-9,10-dione[(1Z)-3,3-dimethyl-3,4-dihydroisoquinolin-1(2H)-ylidene]hydrazone anion (L), was synthesized for the first time. The crystal structure of I was solved. The L-H and L-H' anions exist as cis- and trans-isomers and are linked to the central Ni2+ atom in a tridentate chelating mode giving rise to two conjugated five-membered metal rings of different composition (NiN3C and NiONC2) at each anion. The Ni2+ coordination polyhedron is a highly distorted octahedron whose axial positions are occupied by N(3) and N(3)' atoms. The vertices of the tetrahedrally distorted equatorial base of the octahedron are occupied by the N(1) and N(1)' atoms of the dihydroisoquinoline fragment (A) and the O(1) and O(1)' atoms of the phenanthrenequinone fragment (B). Complex I occurs as the cis-isomer. The conformations of the L-H anions in I and the L molecules in L center dot H2O do not differ much. The randomly disordered CHCl3 solvent molecules in I occupy crystal voids between the centrosymmetric dimeric associates. Spectroscopic (IR and UV-Vis) characteristics of I were obtained.
查看更多

同类化合物

()-2-(5-甲基-2-氧代苯并呋喃-3(2)-亚乙基)乙酸乙酯 (甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (反式)-4-壬烯醛 (双(2,2,2-三氯乙基)) (乙腈)二氯镍(II) (乙基N-(1H-吲唑-3-基羰基)ethanehydrazonoate) (βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (±)17,18-二HETE (±)-辛酰肉碱氯化物 (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (s)-2,3-二羟基丙酸甲酯 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 ([2-(萘-2-基)-4-氧代-4H-色烯-8-基]乙酸) ([1-(甲氧基甲基)-1H-1,2,4-三唑-5-基](苯基)甲酮) (Z)-5-辛烯甲酯 (Z)-4-辛烯醛 (Z)-4-辛烯酸 (Z)-3-[[[2,4-二甲基-3-(乙氧羰基)吡咯-5-基]亚甲基]吲哚-2--2- (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-(-)-5'-苄氧基苯基卡维地洛 (S)-(-)-2-(α-(叔丁基)甲胺)-1H-苯并咪唑 (S)-(-)-2-(α-甲基甲胺)-1H-苯并咪唑 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-(+)-5,5'',6,6'',7,7'',8,8''-八氢-3,3''-二叔丁基-1,1''-二-2-萘酚,双钾盐 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-盐酸沙丁胺醇 (S)-溴烯醇内酯 (S)-氨氯地平-d4 (S)-氨基甲酸酯β-D-O-葡糖醛酸 (S)-8-氟苯并二氢吡喃-4-胺 (S)-7,7-双[(4S)-(苯基)恶唑-2-基)]-2,2,3,3-四氢-1,1-螺双茚满 (S)-4-(叔丁基)-2-(喹啉-2-基)-4,5-二氢噁唑 (S)-4-氯-1,2-环氧丁烷 (S)-3-(((2,2-二氟-1-羟基-7-(甲基磺酰基)-2,3-二氢-1H-茚满-4-基)氧基)-5-氟苄腈 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-3-(2-(二氟甲基)吡啶-4-基)-7-氟-3-(3-(嘧啶-5-基)苯基)-3H-异吲哚-1-胺 (S)-2-(环丁基氨基)-N-(3-(3,4-二氢异喹啉-2(1H)-基)-2-羟丙基)异烟酰胺 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[[[(1R,2R)-2-[[[3,5-双(叔丁基)-2-羟基苯基]亚甲基]氨基]环己基]硫脲基]-N-苄基-N,3,3-三甲基丁酰胺 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-2-N-Fmoc-氨基甲基吡咯烷盐酸盐 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (SP-4-1)-二氯双(喹啉)-钯 (SP-4-1)-二氯双(1-苯基-1H-咪唑-κN3)-钯